Domicile
Groupes
Pages
Marketplace
Plus
Groupes Pages Marketplace Evènements Blogs Financement Offres Courses
Se connecter S’enregistrer
Mode nuit
Alzheimer’s Disease Biomarkers Market to Surpass US$ 1.7 Bn by 2031, Driven by Rising Dementia Prevalence and Advances in Early Diagnosis
The global Alzheimer’s disease biomarkers market is witnessing steady expansion as the prevalence of Alzheimer’s disease and other forms of dementia continues to rise worldwide. Alzheimer’s disease is a progressive and irreversible neurodegenerative disorder that affects memory, cognition, behavior, and functional independence. Biomarkers provide measurable indicators of...
0 Commentaires ·0 Parts ·41 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!